GlassScriptPhysician profile
John A Phillips
NPI 1922120732
$410,211.96
in general payments reported to CMS, 2019-2025
34 companies · $58K in 2025
The $58K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $25K · 2021: $37K · 2022: $75K · 2023: $54K · 2024: $81K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $90K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Honoraria: $15K · Travel and Lodging: $14K · Food and Beverage: $9,034 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $90,302.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62,287.50 |
| Honoraria | $14,625.00 |
| Travel and Lodging | $13,751.82 |
| Food and Beverage | $9,034.36 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,381.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $97,006.82 | 2019-2025 | Zilver Ptx, Micropuncture, Advance |
| Janssen Pharmaceuticals, INC | $69,193.21 | 2019-2024 | Xarelto |
| Philips North America LLC | $64,809.17 | 2020-2025 | (9520) Igt Devices Undivided, US Eq Undivided, (6554) Peripheral Vascular Undivided |
| Boston Scientific Corporation | $50,284.28 | 2019-2025 | Angiojet Xmi, General - Therapies, Eluvia |
| Abbott Laboratories | $42,035.02 | 2019-2025 | Esprit, Jeti, Emboshield Nav6 |
| Bard Peripheral Vascular, INC. | $23,763.68 | 2019-2022 | |
| Cook Medical LLC | $13,666.39 | 2019-2025 | Cook, Zilver Ptx, Zenith |
| Venturemed Group, INC. | $12,292.40 | 2019-2021 | |
| Medtronic, INC. | $6,745.34 | 2021-2025 | Symplicity G3, Endurant Iis, Onyx Frontier |
| Reflow Medical INC | $6,283.34 | 2023-2025 | |
| Cagent Vascular INC | $5,964.18 | 2021-2025 | Serrantor |
| Cardiovascular Systems INC. | $3,855.14 | 2019-2023 | |
| Siemens Medical Solutions USA, INC. | $3,527.81 | 2019-2020 | |
| Shockwave Medical, INC | $3,086.14 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $2,918.32 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,801.00 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $665.39 | 2022-2025 | Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $416.13 | 2019-2021 | |
| Avinger INC. | $407.72 | 2019-2023 | Pantheris |
| Corindus INC. | $393.60 | 2019 | |
| Zoll Circulation INC | $150.00 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Kite Pharma, INC. | $146.82 | 2025 | Yescarta |
| Endologix LLC | $128.56 | 2025 | Endocross Device, Torus Stent Graft System |
| Teleflex LLC | $125.57 | 2019 | |
| Mercator Medsystems, INC. | $123.12 | 2025 | Bullfrog Micro-Infusion Device |
| Penumbra, INC. | $121.50 | 2025 | Indigo System |
| Organogenesis INC. | $106.15 | 2024 | |
| Biocompatibles, INC. | $84.44 | 2019 | |
| Stryker Corporation | $55.36 | 2025 | Artix Mt |
| Edwards Lifesciences Corporation | $28.63 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Imperative Care, INC | $15.36 | 2023 | Symphony Catheter |
| Cardinal Health 200 LLC | $11.37 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$70,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.